<VariationArchive RecordType="classified" VariationID="870456" VariationName="NM_002516.4(NOVA2):c.701_720dup (p.Ala241fs)" VariationType="Duplication" Accession="VCV000870456" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-05-04" MostRecentSubmission="2020-05-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="858624" VariationID="870456">
      <GeneList>
        <Gene Symbol="NOVA2" FullName="NOVA alternative splicing regulator 2" GeneID="4858" HGNC_ID="HGNC:7887" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45933734" stop="45973865" display_start="45933734" display_stop="45973865" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="46442770" stop="46476656" display_start="46442770" display_stop="46476656" Strand="-" />
          </Location>
          <OMIM>601991</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002516.4(NOVA2):c.701_720dup (p.Ala241fs)</Name>
      <CanonicalSPDI>NC_000019.10:45940621:GGCTGGCAGCACATCCGCGGGGCTGGC:GGCTGGCAGCACATCCGCGGGGCTGGCAGCACATCCGCGGGGCTGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="45940621" stop="45940622" display_start="45940621" display_stop="45940622" variantLength="20" positionVCF="45940621" referenceAlleleVCF="C" alternateAlleleVCF="CGGCTGGCAGCACATCCGCGG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="46443879" stop="46443880" display_start="46443879" display_stop="46443880" variantLength="20" positionVCF="46443879" referenceAlleleVCF="C" alternateAlleleVCF="CGGCTGGCAGCACATCCGCGG" />
      </Location>
      <ProteinChange>A241fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.45940629_45940648dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.45940629_45940648dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.46443887_46443906dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.46443887_46443906dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002516.4" sequenceAccession="NM_002516" sequenceVersion="4" change="c.701_720dup" MANESelect="true">
            <Expression>NM_002516.4:c.701_720dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002507.1" sequenceAccession="NP_002507" sequenceVersion="1" change="p.Ala241fs">
            <Expression>NP_002507.1:p.Ala241fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601991.0003" DB="OMIM" />
        <XRef Type="rs" ID="1967741450" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002516.4(NOVA2):c.701_720dup (p.Ala241fs) AND Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities" Accession="RCV001090016" Version="1">
        <ClassifiedConditionList TraitSetID="53421">
          <ClassifiedCondition DB="MedGen" ID="C5394311">Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-04-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-04-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-05-04" MostRecentSubmission="2020-05-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32197073</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="53421" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="52380" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities</ElementValue>
                <XRef ID="MONDO:0030024" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NEDASB</ElementValue>
                <XRef Type="MIM" ID="618859" DB="OMIM" />
              </Symbol>
              <XRef ID="C5394311" DB="MedGen" />
              <XRef ID="MONDO:0030024" DB="MONDO" />
              <XRef Type="MIM" ID="618859" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2466344" SubmissionDate="2020-04-30" DateLastUpdated="2020-05-04" DateCreated="2020-05-04">
        <ClinVarSubmissionID localKey="601991.0003_NEURODEVELOPMENTAL DISORDER WITHOUT AUTISTIC FEATURES AND WITH STRUCTURAL BRAIN ABNORMALITIES" title="NOVA2, 20-BP DUP, NT701_NEURODEVELOPMENTAL DISORDER WITHOUT AUTISTIC FEATURES AND WITH STRUCTURAL BRAIN ABNORMALITIES" />
        <ClinVarAccession Accession="SCV001245424" DateUpdated="2020-05-04" DateCreated="2020-05-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 4-year-old girl (patient 3) with neurodevelopmental disorder without autistic features and with structural brain abnormalities (NEDASB; 618859), Mattioli et al. (2020) identified a de novo heterozygous 20-bp duplication (c.701_720dup, NM_002516.3) in exon 4 of the NOVA2 gene, predicted to result in a frameshift and premature termination (Ala241ProfsTer162). The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, was not present in public databases, including gnomAD. The mutation was predicted to remove the third KH domain of the protein, which binds certain RNA loops. Since the mutation occurs in the last exon, it likely escapes nonsense-mediated mRNA decay, but NOVA2 is not expressed in blood cells, precluding confirmation. Functional studies of the variant and studies of patient cells were not performed, but the authors postulated that the mutation results in a partial loss-of-function rather than a dominant-negative effect.</Attribute>
              <Citation>
                <ID Source="PubMed">32197073</ID>
              </Citation>
              <XRef DB="OMIM" ID="618859" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NOVA2" />
          </GeneList>
          <Name>NOVA2, 20-BP DUP, NT701</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">20-BP DUP, NT701</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601991.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEVELOPMENTAL DISORDER WITHOUT AUTISTIC FEATURES AND WITH STRUCTURAL BRAIN ABNORMALITIES</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

